Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)

Total 48360 results

Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

United States, Australia, New Zealand
Central Denmark Region

Not yet recruiting

Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease (STOP-COPD)

COPD Exacerbation | COPD Exacerbation Acute
AstraZeneca

Recruiting

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations (MIRANDA)

Chronic Obstructive Pulmonary Disease (COPD)

China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
Bnai Zion Medical Center

Completed

Acupuncture Treatment of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

COPD Exacerbation

Israel
Erasme University Hospital

Completed

Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation

COPD Exacerbation

Belgium
University Hospital, Brest

Completed

Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease (SAVE)

Smoking | Chronic Obstructive Pulmonary Disease | COPD Exacerbation

France
Novartis Pharmaceuticals

Completed

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251

Chronic Obstructive Pulmonary Disease, COPD

Poland, United States
Penang Hospital, Malaysia

Completed

Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage (LEGA)

Chronic Obstructive Pulmonary Disease (COPD) | Chronic Bronchiectasis

Malaysia
Western Norway University of Applied Sciences

Recruiting

Digital Follow-up Program for People With Chronic Obstructive Pulmonary Disease in Primary Healthcare

COPD Chronic Obstructive Pulmonary Disease

Norway
AstraZeneca

Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)

COPD (Chronic Obstructive Pulmonary Disease)

France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
University of Alberta
Alberta Health services; Boehringer Ingelheim

Active, not recruiting

Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data

Chronic Obstructive Pulmonary Disease (COPD

Canada
AstraZeneca

Completed

A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
Hvidovre University Hospital
University Hospital Bispebjerg and Frederiksberg; Örebro University, Sweden

Completed

Automated Oxygen Titration in Daily Life in Patients With COPD on Home Oxygen (DaiLiHOT_1)

COPD (Chronic Obstructive Pulmonary Disease)

Denmark
Sunovion

Completed

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada
AstraZeneca

Completed

Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler

COPD Method Evaluation | Chronic Obstructive Pulmonary Disease Method Evaluation

United Kingdom, Sweden
Danbury Hospital

Not yet recruiting

Curcumin in Management of Chronic Obstructive Pulmonary Disease

COPD

United States
Macquarie University, Australia

Completed

The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves.

Chronic Obstructive Pulmonary Disease (COPD)

Australia
Mylan Inc.
Theravance Biopharma

Completed

TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
Johns Hopkins University
National Institute of Environmental Health Sciences (NIEHS)

Completed

Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health

Chronic Obstructive Pulmonary Disease (COPD)

United States
AstraZeneca

Completed

A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, Belgium
Translational Research Center for Medical Innovation...
Kobe City Medical Center General Hospital

Completed

Study of Long-term HFNC for COPD Patients With HOT (FLOCOP)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Pearl Therapeutics, Inc.

Completed

Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Kaiser Permanente
Patient-Centered Outcomes Research Institute

Completed

Walk On! Physical Activity Coaching

Chronic Obstructive Pulmonary Disease (COPD)

United States
Fu Jen Catholic University

Completed

Hemodynamic Effects of Negative Pressure Ventilation in Chronic Obstructive Pulmonary Disease

COPD

Taiwan
Ottawa Hospital Research Institute

Completed

Feasibility and Safety of Immunoglobulin (Ig) Treatment in COPD Outpatients With Frequent Exacerbations: Pilot Study 1

Chronic Obstructive Pulmonary Disease (COPD)

Canada
AstraZeneca

Completed

Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients (MARU)

Chronic Obstructive Pulmonary Disease (COPD)

China
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; National Institute for Health Research: CLAHRC YH; The... and other collaborators

Completed

Use of the SMART COPD Physical Activity App in Pulmonary Rehabilitation

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Conde, Bebiana, M.D.
ResMed

Unknown

TELE-monitoring in Chronic Obstructive Pulmonary Disease (TELECOPD)

COPD

Portugal
Universidad de Granada

Unknown

Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

COPD

Spain
University of Aarhus
Eurostars

Unknown

Feasibility & Effect of a Tele-rehabilitation Program for Chronic Obstructive Pulmonary Disease vs. Standard Rehabilitation (TELEKOL-1)

COPD

Denmark
Loughborough University

Completed

Sedentary Behaviour, Physical Activity and Cardiometabolic Risk in Chronic Obstructive Pulmonary Disease (SPAaRC)

COPD

United Kingdom
Imperial College London

Completed

Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Weill Medical College of Cornell University

Completed

Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers

Chronic Obstructive Pulmonary Disease (COPD)

United States
University Hospital Heidelberg
Hannover Medical School; Philipps University Marburg Medical Center

Completed

Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT (MR-COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Pearl Therapeutics, Inc.

Completed

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Australia, New Zealand
Lutheran Hospital, Indiana
Fisher and Paykel Healthcare

Unknown

The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy

Chronic Obstructive Pulmonary Disease | COPD

United States
Novartis Pharmaceuticals

Completed

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol (REVERBREZ)

Chronic Obstructive Pulmonary Disease (COPD)

France
Rigshospitalet, Denmark

Completed

Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease (COPD)

COPD

Denmark
Maquet Cardiopulmonary AG

Withdrawn

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) (PALP-COPD)

Chronic Obstructive Pulmonary Disease | COPD

Germany
Novartis Pharmaceuticals

Completed

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Egypt, Hungary, France, Guatemala, Panama, Slovakia, Slovenia
McGill University Health Centre/Research Institute...
GlaxoSmithKline

Completed

Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation

Chronic Obstructive Pulmonary Disease | COPD

Canada
Fudan University
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
Patrick Murphy
Philips Respironics

Completed

Validation of the AVAPS AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD) Patients (AVAPS-AE)

OSA | COPD

United Kingdom
Xiromed LLC
Laboratorios Liconsa; Exeltis

Completed

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ARBORUS)

COPD

United States, India
Zuyderland Medisch Centrum

Completed

15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease (MORTCOP)

Mortality | Chronic Obstructive Pulmonary Disease | Exacerbation Copd

Netherlands
AstraZeneca

Recruiting

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

COPD (Chronic Obstructive Pulmonary Disease)

United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Bulgaria, Canada, India, Poland
Hoffmann-La Roche

Recruiting

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)

Chronic Obstructive Pulmonary Disease (COPD)

United States, China, Spain, Italy, Belgium, Korea, Republic of, Poland, Taiwan, Israel, United Kingdom, Japan, Czechia, New Zealand, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, France, India, Canada, ... and more
NanoVation

Completed

Clinical Evaluation of SenseGuard™ to Detect Respiratory Changes, During Home Monitoring of Subjects With High Risk of AECOPD.

Chronic Obstructive Pulmonary Disease (COPD)

Israel
AstraZeneca
Amgen

Completed

Tezepelumab COPD Exacerbation Study (COURSE)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Duke... and other collaborators

Completed

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2) (CAPTURE)

Chronic Obstructive Pulmonary Disease (COPD)

United States

Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations